Medicare drug price negotiation is now in effect for 2026, with a $2,000 out-of-pocket cap and lower Maximum Fair Prices on 10 drugs including Eliquis, Jardiance, and Enbrel. Here is what seniors need to know about savings and plan selection.
By the SeniorSimple Editorial Team | Last updated: May 2026 | Reviewed quarterly
Quick Answer: Starting January 1, 2026, Medicare Part D caps out-of-pocket drug costs at $2,000/year — down from unlimited in prior years. The Inflation Reduction Act (IRA) also enables Medicare to directly negotiate prices on select high-cost drugs. Ten negotiated drugs including Eliquis, Jardiance, and Enbrel now have lower Maximum Fair Prices, saving some seniors thousands annually.
Two major changes from the Inflation Reduction Act took effect January 1, 2026:
| Change | What It Means |
|---|---|
| $2,000 Out-of-Pocket Cap | Maximum you pay for Part D covered drugs per year — then $0 for the rest of the year |
| Negotiated Drug Prices | Medicare now negotiates Maximum Fair Prices (MFPs) on selected high-cost drugs — lower ceiling prices for all Part D plans |
Before the IRA, there was no cap on Medicare Part D out-of-pocket drug spending. Beneficiaries with expensive conditions could pay $10,000–$15,000/year in drug costs. The $2,000 cap is the most significant beneficiary protection in Medicare's history.
Medicare negotiated prices for 10 high-cost drugs take effect January 1, 2026. These are among the most expensive drugs in the Medicare program by total spend.
| Drug Name | Condition Treated | List Price (2024) | Negotiated Price | Est. Savings |
|---|---|---|---|---|
| Eliquis (apixaban) | Blood clots, AFib | $592/mo | $231/mo | 61% |
| Jardiance (empagliflozin) | Type 2 diabetes, heart failure | $595/mo | $197/mo | 67% |
| Xarelto (rivaroxaban) | Blood clots, AFib | $517/mo | $197/mo | 62% |
| Januvia (sitagliptin) | Type 2 diabetes | $527/mo | $113/mo | 79% |
| Farxiga (dapagliflozin) | Type 2 diabetes | $556/mo | $179/mo | 68% |
| Entresto (sacubitril/valsartan) | Heart failure | $573/mo | $295/mo | 49% |
| Enbrel (etanercept) | Rheumatoid arthritis | $7,106/mo | $2,355/mo | 67% |
| Imbruvica (ibrutinib) | Blood cancers | $14,934/mo | $9,319/mo | 38% |
| Stelara (ustekinumab) | Psoriasis, Crohn's disease | $13,836/mo | $4,695/mo | 66% |
| Fiasp/NovoLog (insulin aspart) | Diabetes | $495/mo | $119/mo | 76% |
Source: CMS Medicare Drug Price Negotiation Program Final Prices, August 2024
The cap applies automatically — you do not need to enroll in anything special.
Key details:
Who benefits most: Seniors taking multiple brand-name drugs or specialty medications. A senior on Enbrel for rheumatoid arthritis previously faced tens of thousands per year — the $2,000 cap fundamentally changes that math.
Even with negotiated prices, your savings depend on whether your Part D plan covers the drug on its formulary and which tier it places it on. Use Medicare's Plan Finder at medicare.gov/plan-compare to check your specific situation.
If your income is at or below 150% of the federal poverty level (approximately $21,870 for individuals in 2026), you may qualify for Extra Help — which reduces or eliminates your Part D premiums and copayments entirely. Apply at SSA.gov or call 1-800-772-1213.
Even on Medicare, some manufacturer patient assistance programs can supplement your coverage. NeedyMeds.org and RxAssist.org maintain current directories of available programs by drug and manufacturer.
A plan with a $0 premium may have higher drug copays or a formulary that excludes your medications. Always run your specific drug list through the Plan Finder to compare total annual costs, not just the monthly premium.
You do not need to do anything to receive the benefit of the $2,000 out-of-pocket cap. It applies to all creditable Part D coverage automatically starting January 1, 2026.
The IRA mandates Medicare negotiate prices on an increasing number of drugs each year: 10 in 2026, 15 more in 2027, 15 in 2028, and 20 per year from 2029 onward. Your specific drug may be included in future rounds.
If you have a Medicare Advantage plan with drug coverage (MA-PD), you also benefit from the $2,000 cap and the negotiated drug prices. The changes apply to all creditable Part D coverage.
The Annual Enrollment Period (AEP) runs October 15 – December 7 each year. This is when you can switch Part D or Medicare Advantage plans to take full advantage of updated formularies and negotiated pricing.
Information sourced from Centers for Medicare and Medicaid Services (CMS) Medicare Drug Price Negotiation Program announcements, Kaiser Family Foundation Medicare Drug Negotiation analysis (October 2024), and CMS Medicare Plan Finder data. Drug prices represent published list prices and Maximum Fair Prices (MFPs) as published by CMS. Always verify current pricing at medicare.gov.
Which drugs did Medicare negotiate prices on for 2026?
Medicare negotiated prices on 10 drugs effective January 1, 2026: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp/NovoLog insulin aspart.
How much is the Medicare out-of-pocket drug cap in 2026?
The cap is $2,000/year for Medicare Part D out-of-pocket drug costs, effective January 1, 2026. After reaching $2,000 in covered drug spending, you pay $0 for covered drugs for the rest of the calendar year.
Will negotiated Medicare drug prices automatically apply to my plan?
Yes, if your plan covers the negotiated drug. Negotiated prices (Maximum Fair Prices) are the ceiling — plans cannot charge more. Your actual copay depends on plan tier placement. Use medicare.gov to verify your plan's specific cost sharing.
Does the $2,000 cap apply to Medicare Advantage plans?
Yes. The cap applies to all creditable Part D drug coverage, including Medicare Advantage plans with drug coverage (MA-PD plans).
What is Extra Help and do I qualify?
Extra Help (Low Income Subsidy) reduces Part D premiums and cost sharing for beneficiaries with limited income and resources. Income below approximately $21,870/individual or $29,580/couple qualifies for full Extra Help in 2026. Apply at SSA.gov.
I take Eliquis — how much will I save in 2026?
Eliquis's Maximum Fair Price is $231/month vs. the $592 list price — a 61% reduction. Your actual out-of-pocket cost depends on your plan's tier assignment and copay structure. Use Medicare's Plan Finder to see your exact cost.
When can I switch Part D plans to take advantage of negotiated prices?
The Annual Enrollment Period (October 15 – December 7) is the primary window to switch plans. Special Enrollment Periods may apply for qualifying life events.
Are more drugs being negotiated in future years?
Yes. The IRA requires Medicare to negotiate prices on 15 more drugs in 2027, 15 in 2028, and 20 per year from 2029 onward. The program expands significantly each year.
Disclaimer: Medicare rules and drug pricing change annually. This article reflects information available as of May 2026. Always verify coverage details with your specific plan and at medicare.gov. This content is for informational purposes only and does not constitute medical or insurance advice. Last reviewed May 2026.
Author: SeniorSimple Editorial Team. Our contributors include Medicare licensed insurance agents, healthcare policy researchers, and senior financial planning specialists.
Estimate your Medicare costs and compare plan options
Affects IRMAA surcharges for higher earners
Enter your information to see Medicare cost estimates
Medicare covers GLP-1 drugs for type 2 diabetes — Ozempic and Mounjaro are covered under Part D. Wegovy is now covered for patients with cardiovascular disease following the 2024 SELECT trial results. Weight loss alone is not a covered indication. The 2026 Part D out-of-pocket cap is $2,000.
The best Medicare Part D drug plans of 2026 reviewed by cost and coverage: AARP MedicareRx Preferred earns the highest 4.5-star CMS rating with the broadest formulary, SilverScript Plus offers the best value for generic users, and Humana Premier Rx leads on premium cost at $9.70/month. In 2026, the new $2,000 out-of-pocket cap makes plan selection more important than ever.
Claiming Social Security at 62 permanently reduces your benefit by 25–30%. Waiting to 70 increases it by 24–32% above your Full Retirement Age benefit. The break-even age where waiting pays off is typically 78–83 depending on comparison. This guide walks through every scenario with real numbers.
Get expert insights and practical advice delivered to your inbox weekly.
Join 50,000+ seniors making informed retirement decisions.
